ArticleMicrobiology spectrum2025
Evaluation of capsule polysaccharide (CPS)-specific antibodies for broad recognition of prominent multidrug-resistant
Frank R DeLeo, Brett Freedman, Adeline R Porter, Clement Opoku-Temeng, Scott D Kobayashi, Liang Chen, Barry N Kreiswirth
Abstract read
In one paragraphArticle in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Frank R DeLeoLaboratory of Bacteriology, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA.ORCID 0000-0003-3150-2516 Brett FreedmanLaboratory of Bacteriology, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA.
Adeline R PorterLaboratory of Bacteriology, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA.
Clement Opoku-TemengLaboratory of Bacteriology, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA.
Scott D KobayashiLaboratory of Bacteriology, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA.
Liang ChenDivision of Clinical and Translational Therapeutics, Department of Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University at Buffalo, Buffalo, New York, USA.ORCID 0000-0001-5845-2235 Barry N KreiswirthCenter for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.ORCID 0000-0002-0243-131X Funding
NHLBI NIH HHS
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Antibodies, BacterialBacterial CapsulesDrug Resistance, Multiple, BacterialKlebsiella InfectionsKlebsiella pneumoniaePolysaccharides, BacterialAnimalsAnti-Bacterial AgentsHumansNeutrophilsRabbitsAnti-Bacterial AgentsAntibodies, BacterialPolysaccharides, Bacterialantibiotic resistancecarbapenem-resistanceCPS-conjugateimmunizationopsonophagocytosis
Identifiers
PMID40401961
PMCPMC12211029
What OpenQuestion holds
Textmetadata
Read underepoch 390